NCT03833700 2026-02-27A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Eisai Inc.Phase 1 Active not recruiting70 enrolled
NCT03093116 2025-07-10TRIDENT-1Turning Point Therapeutics, Inc.Phase 1/2 Recruiting500 enrolled 2 FDA
NCT04207463 2020-06-17A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Unknown150 enrolled